The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology

被引:110
作者
Balen, A [1 ]
机构
[1] Gen Infirm, Dept Reprod Med, Leeds LS2 9NS, W Yorkshire, England
关键词
hyperandrogenism; insulin resistance; luteinising hormone; polycystic ovary syndrome;
D O I
10.1016/j.bpobgyn.2004.05.004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The pathophysiology of the polycystic ovary syndrome (PCOS) encompasses inherent ovarian dysfunction that is strongly influenced by external factors, such as disturbances of the hypothalamic-pituitary-ovarian axis and hyperinsulinaemia. Exaggerated gonadotrophin releasing hormone (GnRH) pulsatility results in hypersecretion of luteinising hormone (LH), which has effects both on ovarian androgen production and oocyte development. Disturbed ovarian-pituitary and hypothalamic feedback accentuates the 0gonadotrophin abnormalities. Hyperinsulinaemia is secondary both to insulin resistance at the periphery and to abnormal pancreatic beta cell function. PCOS runs in families and a number of genetic abnormalities appear to result in features of the syndrome and account for the heterogeneity of the symptoms. Environmental influences, such as nutrition and lifestyle, further influence expression of the syndrome.
引用
收藏
页码:685 / 706
页数:22
相关论文
共 124 条
[71]   EFFECTS OF ESTROGEN AND PROGESTERONE ON FUNCTIONAL CAPACITY OF GONADOTROPHS [J].
LASLEY, BL ;
WANG, CF ;
YEN, SSC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 41 (05) :820-826
[72]   New approach to polycystic ovary syndrome and other forms of anovulatory infertility [J].
Laven, JSE ;
Imani, B ;
Eijkemans, MJC ;
Fauser, BCJM .
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2002, 57 (11) :755-767
[73]   Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome [J].
Legro, RS ;
Driscoll, D ;
Strauss, JF ;
Fox, J ;
Dunaif, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14956-14960
[74]   MOLECULAR AND CELLULAR ASPECTS OF THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR [J].
LEROITH, D ;
WERNER, H ;
BEITNERJOHNSON, D ;
ROBERTS, CT .
ENDOCRINE REVIEWS, 1995, 16 (02) :143-163
[75]   THE CONTROL OF BIOACTIVE LUTEINIZING-HORMONE SECRETION IN WOMEN WITH POLYCYSTIC OVARY SYNDROME [J].
LOBO, RA ;
SHOUPE, D ;
CHANG, SP ;
CAMPEAU, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 148 (04) :423-428
[76]  
LOBO RA, 1983, FERTIL STERIL, V39, P674
[77]  
Lockwood Gillian M., 2000, Hum Fertil (Camb), V3, P86, DOI 10.1080/1464727002000198751
[78]   Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: A possible mechanism regulating emergence of the dominant follicle [J].
Lockwood, GM ;
Muttukrishna, S ;
Groome, NP ;
Matthews, DR ;
Ledger, WL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (05) :1730-1735
[79]   Metformin in polycystic ovary syndrome: systematic review and meta-analysis [J].
Lord, JM ;
Flight, IHK ;
Norman, RJ .
BRITISH MEDICAL JOURNAL, 2003, 327 (7421) :951-955
[80]  
Lord Jonathan, 2002, Hum Fertil (Camb), V5, P67, DOI 10.1080/1464727022000198952